NCT07146750View on ClinicalTrials.gov

A Bioequivalence Study of Amlitelimab Delivered by 2 Different Devices in Healthy Adult Participants

PHASE1RecruitingINTERVENTIONAL
Enrollment

212

Participants

Timeline

Start Date

August 25, 2025

Primary Completion Date

March 25, 2026

Study Completion Date

April 8, 2026

Conditions
Healthy Volunteers
Interventions
COMBINATION_PRODUCT

SAR445229

Single dose

Trial Locations (1)

33014

RECRUITING

Clinical Pharmacology of Miami- Site Number : 8400001, Miami

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT07146750 - A Bioequivalence Study of Amlitelimab Delivered by 2 Different Devices in Healthy Adult Participants | Biotech Hunter | Biotech Hunter